STADA has continued to grow strongly during challenging times and, despite the difficult operating environment created by the coronavirus pandemic, which has reduced growth rates across most of the consumer health industry, the company doubled its revenue in 2020, following several acquisitions during the year. STADA's recent rapid growth, with an aggressive acquisition strategy and ongoing brand awareness activities, creates optimism for the company's performance in the coming years.
...
Euromonitor International's STADA Arzneimittel AG in Consumer Health (World) Company Profile offers detailed strategic analysis of the company's business, examining its performance in the Consumer Health industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Scope of the Report
Introduction
State of Play
Exposure to Future Growth
Competitive Positioning
Cough, Cold and Allergy (Hay Fever) Remedies
Analgesics
Key Findings
Appendix
STADA has continued to grow strongly during challenging times and, despite the difficult operating environment created by the coronavirus pandemic, which has reduced growth rates across most of the consumer health industry, the company doubled its revenue in 2020, following several acquisitions duri...